Meyka AI API is live for developers.Start building.
Advertisement
InflaRx N.V.

InflaRx N.V. (IFRX) Stock Overview

Explore InflaRx N.V.’s financial performance, market position, analyst ratings, and future outlook.

IFRXNASDAQ
HealthcareBiotechnology
$1.84
$0.16(8.00%)
U.S. Market opens in 43h 16m
Advertisement

InflaRx N.V. (IFRX)

Meyka AI Score

Z

Key Financials

Market Cap132.9M
P/E Ratio-2.65
EPS (TTM)$-0.73
ROE-0.95%
Fundamental Analysis

AI Price Forecasts

1 Month$1.52
3 Months$0.71
1 Year Target$1.07

IFRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of InflaRx N.V. (IFRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.65 and a market capitalization of 132.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.00%
5-Day Change
-23.33%
1-Month Change
-6.60%
3-Month Change
99.98%
6-Month Change
73.58%
Year-to-Date (YTD) Change
82.18%
1-Year Change
116.73%
3-Year Change
-55.66%
5-Year Change
-41.21%
All-Time (Max) Change
-87.73%

Contact Information

49 3641 508 180
Winzerlaer Str. 2, Jena, NaN, 07745

Company Facts

74 Employees
IPO DateNov 7, 2017
CountryDE
Actively Trading

Frequently Asked Questions